According to The Guardian, the US National Institute of Allergy and Infectious Diseases said that ZMappwhich was used during the massive Ebola epidemic in Sierra Leone, Liberia and Guinea, has been dropped along with Remdesivir after two monoclonal antibodies, which block the virus, had substantially more effect, said which was a co-sponsor of the trial.

“From now on, we will no longer say that Ebola is incurable,” said Prof Jean-Jacques Muyembe, the director general of the Institut National de Recherche Biomédicale in DRC, which has overseen the trial. “These advances will help save thousands of lives,” Muyembe added.

“Now that 90% of their patients can go into the treatment centre and come out completely cured, they will start believing it and building trust in the population and community,” he added.

Photo Credit: ChinaFotoPress/Getty Images